SCHEMBL8867935

SCHEMBL8867935

O=C(CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)c3ccc(F)cc3)cc2)cn1)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 4/20 0.51
MCL1 Q07820 4/20 0.51
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
KMT2A Q03164 3/20 0.46
P4HTM Q9NXG6 1/20 0.46
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 2/20 0.44
PPARA Q07869 1/20 0.44
POLB P06746 1/20 0.44
HTT P42858 1/20 0.43
CXCR1 P25024 1/20 0.43
CXCR2 P25025 1/20 0.43
HIF1A Q16665 1/20 0.43
CA2 P00918 1/20 0.42
TP53 P04637 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868573 1.00 BCL2L1 (0.51) BCL2L1MCL1NPC1RAB9AKMT2A
SCHEMBL8867950 0.95 P4HTM (0.48) BCL2L1MCL1NPC1RAB9AKMT2A
SCHEMBL8869506 0.95 P4HTM (0.50) BCL2L1MCL1NPC1RAB9AKMT2A
SCHEMBL8867921 0.93 MAPT (0.54) BCL2L1MCL1NPC1RAB9AKMT2A
SCHEMBL8869589 0.93 MAPT (0.54) BCL2L1MCL1NPC1RAB9AKMT2A
SCHEMBL8869813 0.91 P4HTM (0.52) BCL2L1MCL1NPC1RAB9AKMT2A
SCHEMBL8867891 0.90 P4HTM (0.48) BCL2L1MCL1NPC1RAB9AKMT2A
SCHEMBL8869509 0.90 SMN1; SMN2 (0.54) BCL2L1MCL1NPC1RAB9AKMT2A
SCHEMBL8869875 0.89 P4HTM (0.48) BCL2L1MCL1NPC1RAB9AKMT2A
SCHEMBL8868802 0.89 P4HTM (0.48) BCL2L1MCL1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed